
BC3 Technologies Receives FDA Clearance for SEAL Hemostatic Wound Spray
FDA Approval Paves Way for Commercial Use of First and Only Aerosolized Chitosan for Management of Serious Arterial Hemorrhage BALTIMORE, MARYLAND, USA, March 22, 2023 /EINPresswire.com/ -- BC3 Technologies, a privately held medical device …